Your browser doesn't support javascript.
Characteristics of the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.2 Subvariant in Jilin, China from March to May 2022.
Liu, Han; Wang, Shuai; Yang, Siqi; Luo, Sean X; Jie, Jing; Hua, Shucheng; Peng, Liping; Luo, Jingjing; Song, Lei; Li, Dan.
  • Liu H; Department of Respiratory Medicine, The First Hospital of Jilin University, Changchun 130000, Jilin Province, China.
  • Wang S; Department of Vascular Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun 130000, Jilin Province, China.
  • Yang S; Department of Respiratory Medicine, The First Hospital of Jilin University, Changchun 130000, Jilin Province, China.
  • Luo SX; Department of Vascular Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun 130000, Jilin Province, China.
  • Jie J; Department of Respiratory Medicine, The First Hospital of Jilin University, Changchun 130000, Jilin Province, China.
  • Hua S; Department of Respiratory Medicine, The First Hospital of Jilin University, Changchun 130000, Jilin Province, China.
  • Peng L; Department of Respiratory Medicine, The First Hospital of Jilin University, Changchun 130000, Jilin Province, China.
  • Luo J; Department of Respiratory Medicine, The First Hospital of Jilin University, Changchun 130000, Jilin Province, China.
  • Song L; Department of Respiratory Medicine, The First Hospital of Jilin University, Changchun 130000, Jilin Province, China.
  • Li D; Department of Respiratory Medicine, The First Hospital of Jilin University, Changchun 130000, Jilin Province, China.
J Transl Int Med ; 10(4): 349-358, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-2154569
ABSTRACT
Background and

Objectives:

In the midst of the pandemic, new coronavirus mutants continue to emerge; the most relevant variant worldwide is omicron. Here, patients who recovered from the disease living in Jilin Province were analyzed to identify factors affecting the severity of omicron infection and to provide insights into its spread and early indication.

Methods:

In this study, 311 cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were divided into two groups. Data on the patients' demographic characteristics and laboratory tests, including platelet count (PLT), neutrophil count (NE), C-reactive protein (CRP), serum creatinine (SCR), and neutrophil-to-lymphocyte ratio (NLR), were collected. The biomarkers for moderate and severe coronavirus disease 2019 (COVID-19) and factors affecting the incubation period and time to subsequent negative nucleic acid amplification test (NAAT) were also investigated.

Results:

Age, gender, vaccination, hypertension, stroke, chronic obstructive pulmonary disease (COPD)/chronic bronchitis/asthma, and some laboratory tests were statistically different between the two groups. In the receiver operating characteristic (ROC) analysis, PLT and CRP had higher area under the ROC curve values. In the multivariate analysis, age, hypertension, COPD/chronic bronchitis/asthma, and CRP were correlated with moderate and severe COVID-19. Moreover, age was correlated with longer incubation. In the Kaplan-Meier curve analysis, gender (male), CRP, and NLR were associated with longer time to subsequent negative NAAT.

Conclusions:

Older patients with hypertension and lung diseases were likely to have moderate or severe COVID-19, and younger patients might have a shorter incubation. A male patient with high CRP and NLR levels might take more time to turn back negative in the NAAT.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Topics: Vaccines / Variants Language: English Journal: J Transl Int Med Year: 2022 Document Type: Article Affiliation country: Jtim-2022-0054

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Topics: Vaccines / Variants Language: English Journal: J Transl Int Med Year: 2022 Document Type: Article Affiliation country: Jtim-2022-0054